Cargando…
Characterization and utilization of an international neurofibromatosis web-based, patient–entered registry: An observational study
The neurofibromatoses (neurofibromatosis type 1, neurofibromatosis type 2 and schwannomatosis) are rare disorders having clinical manifestations that vary greatly from patient to patient. The rarity and variability of these disorders has made it challenging for investigators to identify sufficient n...
Autores principales: | Seidlin, Mindell, Holzman, Robert, Knight, Pamela, Korf, Bruce, Rangel Miller, Vanessa, Viskochil, David, Bakker, Annette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482445/ https://www.ncbi.nlm.nih.gov/pubmed/28644838 http://dx.doi.org/10.1371/journal.pone.0178639 |
Ejemplares similares
-
Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry
por: Tabata, Mika M., et al.
Publicado: (2020) -
The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research
por: Radtke, Heather B., et al.
Publicado: (2021) -
Statins, bone, and neurofibromatosis type 1
por: Korf, Bruce R
Publicado: (2008) -
The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities
por: Klesse, Laura J., et al.
Publicado: (2020) -
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists
por: Merker, Vanessa L., et al.
Publicado: (2022)